Canaan Vs. Akero Therapeutics Industry Stock Comparison

Buy

59

CAN
Canaan

Last Price:

$0.80

Seasonality Move:

-7.84%

Buy

53

AKRO
Akero Therapeutics

Last Price:

$49.85

Seasonality Move:

31.46%

Buy

59

Canaan (CAN) is a Buy

Is Canaan a Buy, Sell or Hold?

The current Canaan [CAN] share price is $0.80. The Score for CAN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
CAN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

53

Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

The current Akero Therapeutics [AKRO] share price is $50.56. The Score for AKRO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CAN Stock Price Chart

What is Canaan's stock price today?

The Canaan share price today is $0.80

The current trend is relatively stagnant and CAN is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

The Akero Therapeutics share price today is $50.56

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CAN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.05	Buy
Relative Strength Index (14 RSI):	51.58	Buy
Chaikin Money Flow:	-14700602	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.62 - 0.86)	Buy
Bollinger Bands (100):	(0.62 - 0.96)	Buy

AKRO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.1	Sell
Relative Strength Index (14 RSI):	44.49	Sell
Chaikin Money Flow:	313186	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(50.96 - 54.26)	Sell
Bollinger Bands (100):	(40.21 - 52.45)	Buy

CAN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.87	Sell
20-day SMA:	0.78	Buy
50-day SMA:	0.71	Buy
200-day SMA:	1.28	Sell
8-day EMA:	0.84	Sell
20-day EMA:	0.8	Buy
50-day EMA:	0.77	Buy
200-day EMA:	1.09	Sell

AKRO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	52.02	Sell
20-day SMA:	52.09	Sell
50-day SMA:	51.03	Sell
200-day SMA:	40.4	Buy
8-day EMA:	51.52	Sell
20-day EMA:	51.98	Sell
50-day EMA:	50.51	Buy
200-day EMA:	42.04	Buy

Canaan Earnings Growth & CAN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.22 per share, an increase this year of $0.08 per share, and an increase next year of $0.43 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.64 per share.

Canaan Technical Analysis

	Jul 14	Jul 15	Jul 16	Jul 17	Jul 18	Jul 21	Jul 22	Jul 23	Jul 24	Jul 25
	Jul
	14	15	16	17	18	21	22	23	24	25
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

	Jul 14	Jul 15	Jul 16	Jul 17	Jul 18	Jul 21	Jul 22	Jul 23	Jul 24	Jul 25
	Jul
	14	15	16	17	18	21	22	23	24	25
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):